Expertise in
2
conditions

Xinguang Qiu

No. 1 East Jianshe Road, 
Zhengzhou, CN 
Expertise in
2
conditions
No. 1 East Jianshe Road, 
Zhengzhou, CN 

Overview

Xinguang Qiu practices practicing medicine in Zhengzhou, China.

Qiu is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Breast Cancer, Thyroid Dysgenesis, and Thyroidectomy.

They are actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 1 clinical trial.

Locations

No. 1 East Jianshe Road, Zhengzhou, 450052, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
Enrollment Status: Active_not_recruiting
Publish Date: March 19, 2026
Intervention Type: Drug
Study Drugs: Selpercatinib, Cabozantinib, Vandetanib
Study Phase: Phase 3

57 Total Publications

Corrigendum to "STAT1-TCTN3 axis drives papillary thyroid carcinoma progression by accelerating the cell cycle and promoting tumor cell migration and invasion" [Int. J. Biol. Macromol. 344, Part 1 (2026) 150436].
Corrigendum to "STAT1-TCTN3 axis drives papillary thyroid carcinoma progression by accelerating the cell cycle and promoting tumor cell migration and invasion" [Int. J. Biol. Macromol. 344, Part 1 (2026) 150436].
Journal: International journal of biological macromolecules
Published: April 08, 2026

Frequently Asked Questions about Xinguang Qiu

Is Xinguang Qiu a top-rated expert for Thyroid Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Xinguang Qiu is classified as an Advanced expert for Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xinguang Qiu participate in research or clinical trials?

Yes. Xinguang Qiu has published 57 articles and abstracts on conditions like Thyroid Cancer. You can view a list of Xinguang Qiu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Qiu's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile